文献速递腹部技术与安全US

二维剪切波弹性成像联合MELD评分提高慢加急性乙型肝炎肝衰竭患者的预后准确性

2D shear wave elastography combined with MELD improved prognostic accuracy in patients with acute-on-chronic hepatitis B liver failure.
PubMed 文献 · Eur Radiol · 2018-04-25

研究连续纳入290例慢加急性乙型肝炎肝衰竭患者,评估二维剪切波弹性成像(2D SWE)预测90天结局的准确性,并在179例推导组中构建MELD-SWE评分(1.3×MELD+0.3×2D SWE),在111例验证组中验证。2D SWE预测结局的准确性可比MELD评分(p=0.441),MELD-SWE在推导组(AUROC 0.80 vs 0.76,p=0.040)和验证组(AUROC 0.87 vs 0.82,p=0.018)均显著优于MELD。MELD-SWE评分最佳截断值为46.8。

要点

  • 2D SWE预测ACLF-HBV患者90天结局的准确性可比MELD评分(p=0.441)。
  • MELD-SWE评分公式为1.3×MELD+0.3×2D SWE(kPa),最佳截断值46.8。
  • MELD-SWE在推导组和验证组预测结局均显著优于MELD。

核心结论

  • MELD-SWE评分联合MELD与SWE值,在预测ACLF-HBV患者结局方面优于单独MELD。

研究设计与样本

  • 研究于2013年10月1日至2015年9月30日连续纳入290例患者,顺序采集2D SWE、超声参数、实验室数据和预后评分,记录90天随访期间结局(恢复/稳定或恶化)。在179例推导组中构建MELD-SWE评分,在111例验证组中验证。

关键影像表现/征象

  • 恶化患者2D SWE值高于恢复/稳定患者(p < 0.001)。

诊断标准与关键数值

  • 2D SWE预测ACLF-HBV结局的准确性可比MELD评分(p = 0.441)。
  • 推导组MELD-SWE的AUROC为0.80,MELD为0.76(p = 0.040)。
  • 验证组MELD-SWE的AUROC为0.87,MELD为0.82(p = 0.018)。
  • MELD-SWE评分公式为1.3×MELD + 0.3×2D SWE(kPa)。
  • MELD-SWE评分最佳截断值为46.8。

临床应用与阅片要点

  • 2D SWE是ACLF-HBV患者简便的预后评估工具。
  • MELD-SWE评分在ACLF-HBV结局预测上优于单独MELD。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate accuracy of two-dimensional shear wave elastography (2D SWE) and develop and validate a new prognostic score in predicting prognosis of acute-on-chronic liver failure (ACLF) patients.

METHODS: From 1 October 2013 to 30 September 2015, we consecutively enrolled 290 patients, sequentially collected data (including 2D SWE, ultrasound parameters, laboratory data and prognostic scores) and recorded patients' outcome (recovering/steady or worsening) during a 90-day follow-up period. We evaluated ability of 2D SWE to predict outcomes of acute-on-chronic hepatitis B liver failure (ACLF-HBV) patients. We developed a new score (MELD-SWE, combining MELD and SWE values) for predicting mortality risk of ACLF-HBV in 179 patients in a derivation group, and validated in 111 patients.

RESULTS: 2D SWE values were higher in worsening patients than recovering/steady ones (p < 0.001). Accuracy of 2D SWE in predicting outcomes of ACLF-HBV was comparable to that of the MELD score (p = 0.441). MELD-SWE showed a significantly higher prognostic value than MELD in both derivation (AUROC, 0.80 vs. 0.76, p = 0.040) and validation (AUROC, 0.87 vs. 0.82, p = 0.018) group.

CONCLUSIONS: The MELD-SWE score, combining MELD and SWE values, was superior to MELD alone for outcoming prediction in patients with ACLF-HBV.

KEY POINTS: • 2D SWE is a simple prognostic evaluation tool in patients with ACLF-HBV. • MELD-SWE was created in this study: 1.3×MELD + 0.3×2D SWE (kPa). • MELD-SWE score was superior to MELD alone for outcoming prediction in ACLF-HBV. • In this study, 46.8 was the optimal cut-off value of MELD-SWE score.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Jin JY, Zheng YB, Zheng J, et al. 2D shear wave elastography combined with MELD improved prognostic accuracy in patients with acute-on-chronic hepatitis B liver failure. Eur Radiol. 2018. PMID: 29696433. doi:10.1007/s00330-018-5336-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。